Collection 

Cancer genomics: Mutational landscape

Submission status
Open

This year marks the 15th anniversary of the first whole cancer genome to be sequenced in acute myeloid leukemia cells (Nature. 2008 Nov 6; 456(7218): 66–72). The field has moved on enormously over a short period of time; tumor whole-genome sequencing is now commonplace and fast becoming standard of care. Vast amounts of sequence data are being generated and new ways to analyze these data are regularly put forward – meaning that multiple different approaches can now be used, depending on the questions being addressed. Tumor sequencing is arguably the biggest driving factor behind the development of precision oncology with personalized treatments tailored for each individual. In this collection, we aim to highlight some of the recent advances and address some of the key questions in the field.

Submit manuscript
Submission guidelines
Manuscript editing services
Mutation in DNA

Editors

Collections articles have undergone BJC Reports' standard peer review process and have been subject to all of the journal’s standard policies. This includes the journal’s policy on competing interests. The Editors declare no competing interests with the submissions which they have handled through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.

This Collection has not been supported by sponsorship.